Bangalore, March 09, 2009
Syngene International, a subsidiary of BIOCON Ltd, Indian biotechnology major, announced today its agreement as alliance partner with DuPont Crop Protection. Syngene has been a preferred research service provider to DuPont Crop Protection primarily in the field of discovery chemistry and biology and will now provide integrated research services, through its "one box" model, covering a broad range of R&D technical capabilities to support DuPont’s discovery pipeline.
"Today we recognize our long-standing relationship and take the next step to further advance our collaboration,” said Julia R Wheeler, R&D Director, DuPont Crop Protection.
Goutam Das, CEO Syngene, said, "We are excited at the prospect of supporting DuPont across the discovery and development value chain in an integrated manner. This signifies our competencies in providing innovation based integrated research services from early stage discovery to final production."
About Syngene International Limited
Established in 1994, Syngene is among India’s foremost integrated custom research service providers and provides integrated Chemistry, Biology, Biologics and DMPK-Toxicology services to support development programs of leading players in the global pharmaceutical and agrochemical industries across a range of challenging programs. Located in a Special Economic Zone at Bangalore with a 1200 plus skilled talent pool of scientists, Syngene a "full-service research hub is equipped to partner with clients right from early stage discovery and development to manufacture of complex development compounds for both small and large molecules in the most efficient manner in terms of cost, quality and time.
DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.
Established in 1978, Biocon Limited is recognized as India's premier biotechnology company. Biocon and its two subsidiary companies, Syngene International Ltd and Clinigene International Ltd form a fully integrated biotechnology enterprise, specializing in biopharmaceuticals, custom research and clinical research. With successful initiatives in clinical development, bio-processing and global marketing, Biocon delivers products and solutions to partners and customers across the globe. Many of these products have USFDA and EMEA acceptance.